Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · IEX Real-Time Price · USD
1.270
-0.010 (-0.78%)
At close: Jul 19, 2024, 4:00 PM
1.300
+0.030 (2.36%)
Pre-market: Jul 20, 2024, 9:28 AM EDT

CNTB Statistics

Total Valuation

CNTB has a market cap or net worth of $69.98 million. The enterprise value is $53.72 million.

Market Cap 69.98M
Enterprise Value 53.72M

Important Dates

The last earnings date was Tuesday, April 16, 2024, after market close.

Earnings Date Apr 16, 2024
Ex-Dividend Date n/a

Share Statistics

CNTB has 55.10 million shares outstanding.

Shares Outstanding 55.10M
Owned by Insiders (%) 41.27%
Owned by Institutions (%) 46.39%
Float 14.64M

Valuation Ratios

PE Ratio n/a
Forward PE 0.78
PS Ratio n/a
Forward PS n/a
PB Ratio 5.04
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.99, with a Debt / Equity ratio of 0.00.

Current Ratio 4.99
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2,580.87

Financial Efficiency

Return on equity (ROE) is -46.00% and return on invested capital (ROIC) is -61.15%.

Return on Equity (ROE) -46.00%
Return on Assets (ROA) -39.70%
Return on Capital (ROIC) -61.15%
Revenue Per Employee n/a
Profits Per Employee -$734,605
Employee Count 81
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, CNTB has paid $16,506 in taxes.

Income Tax 16,506
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +12.39% in the last 52 weeks. The beta is -0.39, so CNTB's price volatility has been lower than the market average.

Beta (5Y) -0.39
52-Week Price Change +12.39%
50-Day Moving Average 1.54
200-Day Moving Average 1.35
Relative Strength Index (RSI) 41.05
Average Volume (20 Days) 79,258

Short Selling Information

Short Interest 15,465
Short Previous Month 27,784
Short % of Shares Out 0.05%
Short % of Float n/a
Short Ratio (days to cover) 0.17

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -8.54M
Pretax Income -8.17M
Net Income -59.50M
EBITDA -8.17M
EBIT -8.17M
Earnings Per Share (EPS) -$0.15
Full Income Statement

Balance Sheet

The company has $16.32 million in cash and $63,961 in debt, giving a net cash position of $16.26 million or $0.30 per share.

Cash & Cash Equivalents 16.32M
Total Debt 63,961
Net Cash 16.26M
Net Cash Per Share $0.30
Equity (Book Value) 13.90M
Book Value Per Share 0.25
Working Capital 13.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.59 million and capital expenditures $364,374, giving a free cash flow of -$6.23 million.

Operating Cash Flow -6.59M
Capital Expenditures 364,374
Free Cash Flow -6.23M
FCF Per Share -$0.11
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNTB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 4.25%
Shareholder Yield 4.25%
Earnings Yield -85.03%
FCF Yield -8.90%

Analyst Forecast

The average price target for CNTB is $6.50, which is 411.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.50
Price Target Difference 411.81%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 1.85%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3